Universidad Nacional de Salta: Clinical Trials

6 trials sponsored by Universidad Nacional de Salta, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 unknown. 3 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable3Unknown 2, Completed 1
Phase 11Completed 1
Phase 21Completed 1

Follow Universidad Nacional de Salta: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
University-Based Chagas Testing in Salta Province, Argentina
Rapid diagnostic test (RDT) for Trypanosoma cruzi infection. - Chagas Disease, Trypanosoma Cruzi Infection
CompletedMundo Sano Foundation25682024-09-112026-06-23
Pharmacokinetics and Excretion of Albendazole and Its Metabolites in Saliva
Albendazole - Pharmacological Action
Not applicableUnknownUniversidad Nacional de Salta122022-07-182022-07-14
Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19
IVERMECTIN (IVER P®) arm will receive IVM 600 µg / kg once daily plus standard care. CONTROL arm will receive standard care. - COVID-19 Drug Treatment
Phase 2CompletedLaboratorio Elea Phoenix S.A.452020-05-182020-10-05
Urine Albendazole Levels for Coverage Assessment
Albendazole Pill, High fat content diet, Moderate fat content die - Helminthiasis
Not applicableCompletedUniversidad Nacional de Salta122019-07-172021-05-11
Serum Pharmacokinetic Disposition and Urinary Excretion of Albendazole
Albendazole. - Soil Transmitted Helminthiasis, Neglected Tropical Diseases
Phase 1CompletedUniversidad Nacional de Salta82016-11-212017-06-22
Management of Soil-transmitted Helminthiasis and Strongyloidiasis
Ivermectin + Albendazole - Helminthiasis, Strongyloides Stercoralis Infection
Not applicableUnknownUniversidad Nacional de Salta20002010-12-012011-03-04

Conditions studied

Helminthiasis (2)  ·  COVID-19 (1)  ·  Chagas Disease (1)  ·  Neglected Diseases (1)

Interventions

Albendazole (4)  ·  Ivermectin (2)  ·  Rapid Diagnostic Tests (1)

Countries

Argentina (4)

Top investigators

Adriana Echazu, PhD (1)  ·  Alejandro J Krolewiecki, MD/PhD (1)  ·  Alejandro Krolewiecki, MD, PhD (1)  ·  Ruben O Cimino, PhD (1)

Results publications

PMID 29346367, PMID 34189446